» Articles » PMID: 37970082

Determining the Impact of Vaccination on SARS-CoV-2 RT-PCR Cycle Threshold Values and Infectious Viral Titres

Abstract

Background: As the COVID-19 pandemic continues, efforts to better understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding and transmission in both unvaccinated and vaccinated populations remain critical to informing public health policies and vaccine development. The utility of using real time RT-PCR cycle threshold values (C values) as a proxy for infectious viral litres from individuals infected with SARS-CoV-2 is yet to be fully understood. This retrospective observational cohort study compares quantitative infectious viral litres derived from a focus-forming viral titre assay with SARS-CoV-2 RT-PCR C values in both unvaccinated and vaccinated individuals infected with the Delta strain.

Methods: Nasopharyngeal swabs positive for SARS-CoV-2 by RT-PCR with a C value <27 collected from 26 June to 17 October 2021 at the University of Vermont Medical Center Clinical Laboratory for which vaccination records were available were included. Partially vaccinated and individuals <18 years of age were excluded. Infectious viral litres were determined using a micro-focus forming assay under BSL-3 containment.

Results: In total, 119 specimens from 22 unvaccinated and 97 vaccinated individuals met all inclusion criteria and had sufficient residual volume to undergo viral titring. A negative correlation between RT-PCR C values and viral litres was observed in both unvaccinated and vaccinated groups. No difference in mean C value or viral titre was detected between vaccinated and unvaccinated groups. Viral litres did not change as a function of time since vaccination.

Conclusions: Our results add to the growing body of knowledge regarding the correlation of SARS-CoV-2 RNA levels and levels of infectious virus. At similar C values, vaccination does not appear to impact an individual's potential infectivity when infected with the Delta variant.

Citing Articles

Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.

Garcia-Rodriguez J, Janvier F, Kill C Microorganisms. 2025; 13(1).

PMID: 39858831 PMC: 11767719. DOI: 10.3390/microorganisms13010063.


Saliva as a Biological Fluid in SARS-CoV-2 Detection.

Silva E, Furtado F, Silveira R, Tasca K, Silva C, Godoy A Diagnostics (Basel). 2024; 14(9).

PMID: 38732336 PMC: 11083664. DOI: 10.3390/diagnostics14090922.

References
1.
van Kampen J, van de Vijver D, Fraaij P, Haagmans B, Lamers M, Okba N . Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021; 12(1):267. PMC: 7801729. DOI: 10.1038/s41467-020-20568-4. View

2.
Bruce E, Mills M, Sampoleo R, Perchetti G, Huang M, Despres H . Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples. EMBO Mol Med. 2021; 14(2):e15290. PMC: 8819313. DOI: 10.15252/emmm.202115290. View

3.
Singanayagam A, Hakki S, Dunning J, Madon K, Crone M, Koycheva A . Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2021; 22(2):183-195. PMC: 8554486. DOI: 10.1016/S1473-3099(21)00648-4. View

4.
Ke R, Martinez P, Smith R, Gibson L, Mirza A, Conte M . Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat Microbiol. 2022; 7(5):640-652. PMC: 9084242. DOI: 10.1038/s41564-022-01105-z. View

5.
Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A . Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat Med. 2022; 28(7):1491-1500. DOI: 10.1038/s41591-022-01816-0. View